← Research Products

ACE-031
MODERATE EVIDENCEResearch use only · Investigational — clinical development discontinued
Available vial sizes
1mg
Pricing provided on quote to approved business accounts.
A soluble activin receptor fusion protein studied as a myostatin pathway inhibitor. Clinical development was discontinued after adverse findings in trials.
Documentation
- Certificate of Analysis — available on request
- Batch records — provided to approved accounts
Professional Inquiry
Available actions for this product: Request Information · Request a Quote.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.
